Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Adamantinoma

Back to Topics
Contents
0%

Adamantinoma

Comprehensive guide to adamantinoma - rare low-grade malignant bone tumour with tibial predilection, imaging features, surgical management, and prognosis for orthopaedic exam

complete
Updated: 2025-12-24
High Yield Overview

ADAMANTINOMA - LOW-GRADE EPITHELIAL BONE MALIGNANCY

Tibial Diaphysis | Biphasic Histology | Soap-Bubble Appearance | Wide Excision

85%Occur in tibial diaphysis
20-50Peak age in years
15-30%Metastasis rate
92%10-year survival

HISTOLOGICAL SUBTYPES

Classic
PatternBiphasic - epithelial and osteofibrous components
TreatmentWide en bloc resection with limb salvage
Osteofibrous-like (Differentiated)
PatternPredominant fibrous component, younger patients
TreatmentBetter prognosis, wide excision
Basaloid
PatternBasaloid epithelial pattern
TreatmentWide excision
Squamous
PatternSquamous differentiation
TreatmentWide excision, may have better prognosis

Critical Must-Knows

  • Tibial diaphysis is the classic location (85% of cases)
  • Biphasic histology - epithelial cells in osteofibrous stroma
  • Soap-bubble appearance on X-ray - multilocular lytic lesion
  • Wide en bloc excision required - curettage has high recurrence
  • Cytokeratin positive - distinguishes from other bone tumours

Examiner's Pearls

  • "
    Anterior tibial cortex involvement is characteristic
  • "
    May arise from or coexist with osteofibrous dysplasia
  • "
    Lymph node and lung metastases occur in 15-30%
  • "
    Late recurrence possible - follow up for decades

Clinical Imaging

Imaging Gallery

adamantinoma imaging 1
Click to expand
Clinical imaging for adamantinomaCredit: Unknown via https://pmc.ncbi.nlm.nih.gov/articles/PMC10772315/ (CC-BY-4.0)
adamantinoma imaging 2
Click to expand
Clinical imaging for adamantinomaCredit: Unknown via https://pmc.ncbi.nlm.nih.gov/articles/PMC10772315/ (CC-BY-4.0)
adamantinoma imaging 3
Click to expand
Clinical imaging for adamantinomaCredit: Unknown via https://pmc.ncbi.nlm.nih.gov/articles/PMC9691950/ (CC-BY-4.0)

Critical Adamantinoma Exam Points

Location is Key

Tibial diaphysis is the hallmark location (85%). The lesion characteristically involves the anterior cortex. If you see a lytic tibial diaphyseal lesion in a young adult, consider adamantinoma in the differential.

Biphasic Histology

The tumour contains epithelial nests within an osteofibrous stroma. Epithelial cells are cytokeratin 14 and 19 positive. This biphasic pattern distinguishes it from pure osteofibrous dysplasia.

Surgical Margins Matter

Wide en bloc resection is mandatory. Curettage or marginal excision leads to unacceptably high local recurrence (up to 90%). Intralesional surgery is the strongest predictor of recurrence and metastasis.

Long-term Follow-up

Recurrence can occur up to 36 years after initial resection. Patients require lifelong surveillance. The 10-year survival is excellent at 92% but late metastases occur.

Quick Decision Guide - Differential of Tibial Lytic Lesions

DiagnosisAgeLocationKey Features
Adamantinoma20-50 yearsTibial diaphysis (anterior cortex)Soap-bubble, cytokeratin positive
Osteofibrous dysplasiaUnder 10 yearsTibial diaphysis (anterior cortex)Self-limiting, anterior bowing
Fibrous dysplasiaAny ageAny bone, often polyostoticGround-glass matrix, shepherd's crook
Ewing sarcoma5-25 yearsDiaphysis any bonePermeative, onion-skin periosteal reaction
Osteosarcoma10-25 yearsMetaphysis long bonesAggressive, Codman triangle, sunburst
Mnemonic

TIBIA - Key Features of Adamantinoma

T
Tibial location
85% occur in tibial diaphysis
I
Intermediate grade
Low-grade malignancy with metastatic potential
B
Biphasic histology
Epithelial nests in osteofibrous stroma
I
Immunopositive for cytokeratin
CK14 and CK19 positive
A
Anterior cortex
Characteristically involves anterior tibial cortex

Memory Hook:TIBIA helps remember this is the classic tibial tumour with unique biphasic histology

Mnemonic

WIDE - Surgical Principles

W
Wide margins essential
En bloc resection with wide margins
I
Intralesional causes recurrence
Curettage leads to 90% local failure
D
Decades of follow-up
Late recurrence up to 36 years
E
En bloc with reconstruction
Allograft, vascularised fibula, or prosthesis

Memory Hook:WIDE margins are essential - never curettage adamantinoma

Mnemonic

SOAP - Imaging Features

S
Soap-bubble appearance
Multilocular lytic lesion on X-ray
O
Osteolytic with sclerotic rim
Well-defined with reactive sclerosis
A
Anterior cortex location
Eccentric, anterior tibial cortex
P
Possible multifocality
Skip lesions in same bone possible

Memory Hook:The SOAP-bubble appearance on X-ray is characteristic of adamantinoma

Overview and Epidemiology

Adamantinoma is a rare low-grade malignant bone tumour with distinctive biphasic histology featuring epithelial cells within an osteofibrous stroma. It has a remarkable predilection for the tibial diaphysis and represents less than 0.5% of all primary bone tumours.

Key epidemiological features:

  • Incidence: Accounts for less than 1% of primary malignant bone tumours
  • Age distribution: Peak between 20-50 years (range 2-86 years)
  • Gender: Slight male predominance (5:4 ratio)
  • Location: 80-85% occur in the tibial diaphysis

Risk factors:

  • No established genetic predisposition identified
  • Possible association with osteofibrous dysplasia (OFD)
  • History of prior trauma reported in 60% of patients (uncertain significance)
  • No association with radiation or chemical exposure

Etymology

The name "adamantinoma" derives from Greek "adamantinos" meaning "very hard", coined by Fischer in 1913. The term was originally used for odontogenic tumours with similar histology. Despite the name suggesting a relationship to dental tumours, skeletal adamantinoma is a distinct entity.

Pathophysiology

Histological Features

Adamantinoma is characterised by its distinctive biphasic histology with epithelial and osteofibrous components that may be intermingled in various proportions.

Epithelial Component:

  • Nests, cords, or tubules of epithelial cells
  • Positive for cytokeratins 14, 19 (but negative for CK8, CK18)
  • Four histological patterns: basaloid, tubular, spindle-cell, squamous
  • Peripheral palisading of cells may be seen
H&E histopathology of adamantinoma showing biphasic pattern
Click to expand
Histopathology of adamantinoma (H&E stain) demonstrating the characteristic biphasic pattern: epithelial cell nests arranged in palisading pattern (red arrow) within a fibrous mesenchymal stroma (yellow arrow). The dark-staining epithelial nests are cytokeratin-positive and represent the malignant component, while the surrounding pink fibrous tissue resembles osteofibrous dysplasia.Credit: Patel N, Gupta G, Chawla G, Chhabra M

Osteofibrous Component:

  • Fibrous stroma with woven bone trabeculae
  • Similar to osteofibrous dysplasia
  • Contains scattered osteoclast-like giant cells
  • Positive for vimentin

Relationship to Osteofibrous Dysplasia

A controversial but clinically important relationship exists between adamantinoma and osteofibrous dysplasia (OFD):

FeatureOsteofibrous DysplasiaOFD-like AdamantinomaClassic Adamantinoma
AgeChildren (under 10)AdolescentsAdults (20-50)
Epithelial cellsRare or absentScattered, smallProminent nests
CytokeratinNegative or focalFocal positiveStrongly positive
BehaviourBenign, self-limitingLow malignant potentialMalignant
TreatmentObservation (most)Wide excisionWide excision

Proposed pathogenic relationship:

  • OFD may represent a precursor lesion in some cases
  • OFD-like (differentiated) adamantinoma is an intermediate lesion
  • Transformation from OFD to adamantinoma has been documented
  • All three may represent a spectrum of the same disease process

Molecular Features

  • Chromosomal abnormalities: Extra copies of chromosomes 7, 8, 12, 19, 21
  • No specific fusion genes identified (unlike Ewing sarcoma)
  • GNAS mutations absent (differentiates from fibrous dysplasia)
  • MDM2 amplification absent (differentiates from dedifferentiated liposarcoma)

Classification Systems

Histological Classification

Histological Patterns of Adamantinoma

PatternFeaturesFrequencyPrognosis
BasaloidNests of basaloid cells with peripheral palisadingCommonStandard
TubularEpithelial cells forming tubular/glandular structuresCommonStandard
Spindle-cellElongated spindle-shaped epithelial cellsLess commonMay be confused with sarcoma
SquamousSquamous differentiation with keratinisationLess commonMay have better prognosis
Osteofibrous-like (Differentiated)Predominantly fibrous with scattered epithelial cells10-20%Better prognosis

Most tumours show mixed patterns. The osteofibrous-like (differentiated) subtype has a notably better prognosis and occurs in younger patients.

WHO Classification and Staging

Adamantinoma is classified as a low-grade malignant tumour in the WHO Classification of Tumours of Soft Tissue and Bone.

Musculoskeletal Tumor Society (MSTS) Staging:

MSTS Staging for Adamantinoma

StageGradeCompartmentMetastases
IALow (G1)Intracompartmental (T1)None (M0)
IBLow (G1)Extracompartmental (T2)None (M0)
IIIAnyAnyRegional/distant (M1)

Most adamantinomas present as Stage IB (low-grade, extracompartmental) due to cortical destruction with soft tissue extension.

Clinical Assessment

History

Classic Presentation:

  • Slowly progressive swelling over the anterior shin
  • Dull, aching pain - often present for months to years
  • Approximately 30% have symptoms for more than 5 years before diagnosis
  • May have history of prior trauma (reported in 60%)

Duration of symptoms is an important prognostic factor - shorter symptom duration (less than 5 years) is associated with higher recurrence risk.

Red Flag Symptoms:

  • Rapid increase in swelling
  • New or worsening pain
  • Constitutional symptoms (weight loss, fever) - rare but concerning
  • Pathological fracture (occurs in 16-23% of cases)

Physical Examination

Standard Findings:

  • Palpable firm mass over anterior tibial shaft
  • Overlying skin may be normal or tense
  • Possible anterior tibial bowing
  • Tenderness on palpation
  • Usually no warmth or erythema (unless fracture)

Examination Sequence:

StepAssessmentFindings
1InspectionAnterior tibial swelling, possible bowing
2PalpationFirm, fixed mass arising from bone
3Range of motionUsually preserved at knee and ankle
4NeurovascularUsually normal, check dorsalis pedis
5Lymph nodesPalpate popliteal and inguinal nodes

Differential Diagnosis

Differential Diagnosis of Tibial Lytic Lesions

DiagnosisKey Differentiating Features
Osteofibrous dysplasiaAge under 10, anterior bowing, self-limiting, cytokeratin negative
Fibrous dysplasiaGround-glass matrix, polyostotic form common, GNAS mutation
Ewing sarcomaAge 5-25, permeative, systemic symptoms, EWSR1 translocation
OsteomyelitisFever, elevated WCC/CRP, sequestrum on CT
Metastatic carcinomaKnown primary, older age, multiple lesions common

Investigations

Imaging Algorithm

Step 1: Plain Radiographs

  • First-line investigation for tibial swelling
  • Characteristic "soap-bubble" or multilocular lytic appearance
  • Eccentric location in anterior cortex
  • Sclerotic margins with cortical expansion
  • May show multifocality (skip lesions)
AP and lateral radiographs of right tibia showing adamantinoma
Click to expand
Plain radiographs (AP and lateral) of right tibia demonstrating classic adamantinoma appearance: expansile lytic-sclerotic lesion in the proximal tibial diaphysis (red arrows) with multilocular 'soap-bubble' pattern, internal septation, and partially sclerotic borders. Note the eccentric location involving the anterior tibial cortex - a pathognomonic feature of adamantinoma.Credit: Patel N, Gupta G, Chawla G, Chhabra M

Step 2: CT Scan

  • Better cortical definition than X-ray
  • Defines extent of bone destruction
  • Identifies pathological fracture
  • CT chest for pulmonary metastasis staging

Step 3: MRI

  • Gold standard for local staging
  • Defines intramedullary extent
  • Identifies soft tissue extension
  • Detects skip lesions (multifocality)

Imaging Characteristics

Imaging Modality Comparison

ModalityKey FindingsRole
Plain radiographSoap-bubble appearance, eccentric, sclerotic marginsInitial assessment
CT scanCortical destruction, extent of bone involvementSurgical planning, staging (chest)
MRIT1 low, T2 high signal, contrast enhancement, skip lesionsLocal staging, soft tissue assessment
Bone scanIncreased uptake, identifies multifocal diseaseScreening for metastases
PET-CTFDG avid, useful for staging and recurrenceStaging, surveillance
Comprehensive 15-panel figure showing adamantinoma imaging, surgery, and histopathology
Click to expand
Osteofibrous dysplasia-like adamantinoma: comprehensive workup. Top row (A-F): Lateral radiograph, sagittal CT, T1/T2/post-contrast MRI, and gross surgical specimen. Middle row (G-K): Axial CT and MRI, post-operative radiographs showing fibular graft reconstruction with internal fixation. Bottom row (L-O): Histology showing woven bone trabeculae with small epithelial cell nests (L-M), and immunohistochemistry demonstrating cytokeratin CK19-positive tumour cells (N-O).Credit: Huang Z, Chen K, Ye Z, Yuan J

Biopsy

Principles:

  • Core needle biopsy preferred (CT or ultrasound-guided)
  • Open biopsy if core inconclusive
  • Biopsy tract must be excised with definitive resection
  • Place biopsy tract in line with planned surgical incision

Biopsy Planning

Always discuss biopsy approach with the operating surgeon before performing. The biopsy tract becomes contaminated and must be excised en bloc with the tumour. Poorly placed biopsies can compromise limb salvage.

Laboratory Studies

  • FBC, ESR, CRP - usually normal
  • LDH, ALP - usually normal or mildly elevated
  • Calcium - rarely hypercalcaemia (paraneoplastic)
  • Immunohistochemistry: Cytokeratin 14, 19 positive; CK8, 18 negative

Management

📊 Management Algorithm
adamantinoma management algorithm
Click to expand
Management algorithm for adamantinomaCredit: OrthoVellum

Surgical Principles

Wide En Bloc Resection is the treatment of choice. The goal is complete tumour removal with a cuff of normal tissue.

Margin Types:

MarginDescriptionLocal Recurrence
IntralesionalThrough the tumourUp to 90%
MarginalThrough reactive zone30-50%
WideThrough normal tissueUnder 10%
RadicalEntire compartmentUnder 5%

Never Curettage

Curettage or intralesional excision is contraindicated. This is the strongest predictor of local recurrence and subsequent metastasis. All adamantinomas require wide surgical margins.

Surgical Goals:

  1. Complete tumour removal with wide margins
  2. Excision of biopsy tract
  3. Preservation of limb function when possible
  4. Durable reconstruction

Limb Salvage Reconstruction Options:

Reconstruction Options After Tibial Resection

MethodAdvantagesDisadvantages
Intercalary allograftAnatomical reconstruction, joint preservationNonunion, fracture, infection risk
Vascularised fibula autograftLiving bone, good incorporationDonor morbidity, hypertrophy takes time
Allograft-prosthesis compositeImmediate stability, joint replacementLoosening, wear, infection
Distraction osteogenesisAutologous bone, no donor siteProlonged treatment, pin site issues
EndoprosthesisImmediate functionLoosening, wear, revision

The choice of reconstruction depends on resection length, patient age, expected activity level, and institutional expertise.

Operative Technique - Wide Resection

Pre-operative Planning:

  • Review MRI for tumour extent and skip lesions
  • Plan osteotomy levels with adequate margins (minimum 3-5 cm)
  • Mark biopsy tract for en bloc excision
  • Arrange bone graft or reconstruction materials

Patient Positioning:

  • Supine on radiolucent table
  • Tourniquet on upper thigh (exsanguinate by elevation, not Esmarch)
  • Prepare donor site if vascularised fibula planned

Surgical Steps:

Step 1: Incision Longitudinal incision encompassing biopsy tract with 2 cm margin. Extend proximally and distally beyond planned osteotomy levels.

Step 2: Superficial Dissection Identify and protect great saphenous vein and saphenous nerve. Develop anterior and posterior flaps.

Step 3: Deep Dissection Identify anterior tibial neurovascular bundle in anterior compartment. Protect during dissection. Release tibialis anterior and other anterior compartment muscles from tibia.

Step 4: Posterior Dissection Subperiosteal dissection posteriorly. Identify and protect posterior tibial neurovascular bundle. May need to sacrifice interosseous membrane.

Step 5: Osteotomies Perform proximal and distal osteotomies at planned levels. Ensure adequate margins (check frozen section if concerned).

Step 6: Specimen Removal Remove specimen en bloc with surrounding soft tissue cuff and biopsy tract. Orient and mark specimen for pathology.

Step 7: Reconstruction Perform chosen reconstruction (allograft, vascularised fibula, etc.). Ensure stable fixation.

Step 8: Closure Layered closure over drains. Protect soft tissue envelope.

This achieves oncological resection while preserving limb function.

Adjuvant Therapy

Chemotherapy:

  • Not standard treatment for adamantinoma
  • Limited efficacy in low-grade epithelial tumours
  • May be considered for metastatic disease
  • Multikinase inhibitors (e.g., sunitinib) may prolong survival in advanced disease

Radiotherapy:

  • Not standard treatment
  • Limited role as adamantinoma is relatively radioresistant
  • May be considered for unresectable tumours
  • Palliative role for symptomatic metastases

Treatment of Metastases:

  • Pulmonary metastases: Surgical metastasectomy if feasible
  • Lymph node metastases: Regional lymphadenectomy
  • Multiple metastases: Systemic therapy (limited options)

Follow-up Protocol:

TimepointClinicalImaging
Every 3 months x 2 yearsFull examinationChest X-ray, local X-ray
Every 6 months x 3-5 yearsFull examinationChest X-ray, consider CT
Annually thereafterLifelongChest imaging, local imaging as needed

Lifelong Follow-up

Adamantinoma requires lifelong surveillance. Late recurrences have been documented up to 36 years after initial resection. Annual clinical and radiological follow-up should continue indefinitely.

Complications

Tumour-Related Complications

Tumour-Related Complications

ComplicationIncidenceManagement
Pathological fracture16-23%Stabilisation then definitive resection
Local recurrence10-35% (margin dependent)Re-resection with wider margins, amputation
Pulmonary metastases15-30%Metastasectomy if possible, systemic therapy
Lymph node metastases5-10%Lymphadenectomy

Surgical Complications

ComplicationIncidenceRisk Factors
Wound infection5-15%Large resection, diabetes
Nonunion10-30% (allograft)Long segment, chemotherapy
Fracture (allograft)15-25%Stress risers, activity
Deep venous thrombosis5-10%Prolonged surgery, immobility
Neurovascular injuryUnder 5%Tumour proximity

Managing Recurrence

Local recurrence is the most significant complication. Assessment includes:

  1. Imaging: MRI of local site, CT chest, bone scan/PET
  2. Biopsy: Confirm recurrence histologically
  3. Surgical planning: Review margins from primary surgery

Treatment Options:

  • Wide re-excision if margins achievable
  • Amputation if limb salvage not possible
  • Palliative care for unresectable/metastatic disease

Recurrence Predicts Metastasis

Local recurrence significantly increases the risk of subsequent metastatic disease. Achieving adequate margins at initial surgery is critical to prevent this cascade of complications.

Postoperative Care

Immediate Postoperative Care

Day 0-3:

  • DVT prophylaxis (mechanical and pharmacological)
  • Drain management - remove when output under 50ml per 24 hours
  • Pain management - PCA then oral analgesia
  • Non-weight bearing on affected limb

Week 1-6:

  • Wound surveillance - watch for infection
  • Protected weight bearing (depends on reconstruction)
  • Physiotherapy for ROM and muscle strengthening
  • Monitor for DVT/PE

Rehabilitation Protocol

PhaseTimeframeGoals
Phase 1Weeks 0-6Protected weight bearing, ROM, wound healing
Phase 2Weeks 6-12Progressive weight bearing, strength
Phase 3Months 3-6Full weight bearing, functional activities
Phase 4After 6 monthsReturn to recreational activities

Reconstruction-Specific Considerations:

  • Allograft: Non-weight bearing 6-12 weeks until union
  • Vascularised fibula: Progressive weight bearing as fibula hypertrophies
  • Endoprosthesis: Earlier weight bearing (2-4 weeks)

Return to Activity

  • Desk work: 4-6 weeks (depends on pain control)
  • Manual work: 3-6 months
  • Sports: Generally low-impact activities recommended
  • Driving: When off opioids and can weight bear for emergency stop

Allograft Union

Intercalary allograft reconstruction requires careful monitoring for union. Radiographic union at the allograft-host junction may take 12-18 months. Protect the construct during this period.

Outcomes and Prognosis

Survival Outcomes

Overall Survival:

  • 5-year survival: 95-98%
  • 10-year survival: 87-92%
  • Metastatic disease significantly worsens prognosis

Disease-Free Survival:

  • Recurrence-free survival at 10 years: approximately 72%
  • Late recurrence is a significant concern

Prognostic Factors

Factors Associated with Worse Outcome:

Prognostic Factors

FactorBetter PrognosisWorse Prognosis
Histological subtypeOsteofibrous-like (differentiated)Classic with high epithelial component
Surgical marginsWide or radicalIntralesional or marginal
Symptom durationGreater than 5 yearsLess than 1 year
AgeOlder (over 20)Younger (under 20)
Pain at presentationMinimal or absentSignificant pain
Squamous differentiationPresentAbsent

Functional Outcomes

Limb Salvage:

  • Achievable in 80-90% of cases at specialised centres
  • MSTS functional score typically 70-85% of normal

Quality of Life:

  • Generally good with successful limb salvage
  • May require walking aids initially
  • Long-term surveillance can cause anxiety

Evidence and Guidelines

Surgical Margins and Recurrence

Level IV
Key Findings:
  • Intralesional excision associated with 90% local recurrence
  • Marginal excision: 30-50% recurrence
  • Wide excision: under 10% recurrence
  • Local recurrence increases metastasis risk
Clinical Implication: Wide surgical margins are mandatory - never perform curettage
Source: Keeney et al. JBJS Am 1989; Multiple institutional series

Long-term Outcomes After Wide Resection

Level IV
Key Findings:
  • 10-year survival 87-92%
  • Recurrence can occur up to 36 years post-resection
  • Pulmonary metastases in 15-30%
  • Limb salvage achievable in 80-90%
Clinical Implication: Lifelong follow-up is required due to late recurrence risk
Source: Qureshi et al. JBJS Br 2000; Institutional reviews

OFD-Adamantinoma Relationship

Level IV
Key Findings:
  • Cytokeratin expression in OFD suggests relationship
  • OFD-like adamantinoma represents intermediate lesion
  • Possible progression from OFD to adamantinoma
  • All may represent disease spectrum
Clinical Implication: OFD in adults requires careful evaluation for epithelial component
Source: Hazelbag et al. Cancer 1994; Park et al. Mod Pathol 1993

Reconstruction Outcomes

Level IV
Key Findings:
  • Allograft nonunion 10-30%
  • Allograft fracture 15-25%
  • Vascularised fibula may require prolonged protected weight bearing
  • Endoprosthesis allows earlier function
Clinical Implication: Reconstruction choice depends on patient factors and institutional expertise
Source: Capanna et al. Multiple series; Muscolo et al. CORR 2008

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Classic Tibial Adamantinoma

EXAMINER

"A 28-year-old man presents with a 2-year history of anterior shin swelling. Radiographs show a multilocular lytic lesion in the mid-tibial diaphysis with a soap-bubble appearance and sclerotic margins. There is cortical expansion but no periosteal reaction."

EXCEPTIONAL ANSWER
**Opening Statement:** "This presentation is consistent with adamantinoma - a low-grade malignant bone tumour with a predilection for the tibial diaphysis. The soap-bubble appearance and location are classic features." **Key Assessment Points:** 1. Duration of symptoms and any recent change in size or pain 2. History of prior trauma or previous biopsy 3. Constitutional symptoms (usually absent) 4. Examination of regional lymph nodes **Investigation Approach:** "I would complete staging with: 1. MRI of the entire tibia to assess tumour extent and exclude skip lesions 2. CT chest to stage for pulmonary metastases 3. Core needle biopsy for histological diagnosis I expect histology to show biphasic pattern with cytokeratin-positive epithelial cells in an osteofibrous stroma." **Management Plan:** "Treatment is wide en bloc resection with reconstruction. Curettage is contraindicated due to unacceptably high recurrence rates. I would plan: 1. Wide excision with 3-5 cm margins 2. Excision of biopsy tract 3. Reconstruction - options include intercalary allograft, vascularised fibula, or combination Adjuvant chemotherapy and radiotherapy have limited roles in primary adamantinoma." **Follow-up:** "Lifelong surveillance is required as recurrence can occur up to 36 years post-resection."
KEY POINTS TO SCORE
Recognise classic tibial diaphysis location with soap-bubble appearance
Staging with MRI and CT chest before surgery
Wide en bloc resection is mandatory - never curettage
Cytokeratin immunostaining confirms epithelial component
COMMON TRAPS
✗Suggesting curettage as a treatment option
✗Failing to stage for pulmonary metastases
✗Not planning biopsy tract excision
✗Forgetting need for lifelong follow-up
LIKELY FOLLOW-UPS
"What if histology shows osteofibrous dysplasia with no epithelial cells?"
"How would you manage a pathological fracture through this lesion?"
"What are the reconstruction options after wide tibial resection?"
"What is your approach if margins are positive on final histology?"
VIVA SCENARIOChallenging

Recurrent Adamantinoma

EXAMINER

"A 45-year-old woman had curettage of a tibial lesion 5 years ago at an outside institution. She was told it was 'benign'. She now presents with increasing pain and swelling. MRI shows a large tibial lesion with soft tissue extension. Review of original pathology confirms adamantinoma."

EXCEPTIONAL ANSWER
**Opening Statement:** "This represents local recurrence of adamantinoma following inadequate initial surgery. Curettage for adamantinoma has up to 90% recurrence rate. This case highlights why wide resection is mandatory." **Assessment:** 1. Full staging - CT chest, bone scan or PET-CT 2. Review original pathology and current imaging 3. Assess neurovascular involvement 4. Discuss at multidisciplinary tumour board **Key Concerns:** - Local recurrence increases metastasis risk - Soft tissue extension suggests aggressive biology - Previous surgery may have seeded tumour along biopsy tract - May have contaminated surgical planes **Management Options:** "If limb salvage is possible: - Wide re-excision including all previous surgical scars - May require longer segment resection - Reconstruction with allograft or prosthesis - Consider adjuvant therapy (limited evidence) If limb salvage not possible: - Amputation may be required if tumour involves neurovascular structures or joint - Better than leaving residual disease" **Prognosis:** "Prognosis is worse after recurrence. I would counsel the patient about increased metastasis risk and the possibility that amputation may be necessary if wide margins cannot be achieved."
KEY POINTS TO SCORE
Curettage is never appropriate for adamantinoma
Recurrence increases metastasis risk
Full restaging required
May require amputation if wide margins not achievable
COMMON TRAPS
✗Attempting repeat curettage
✗Not restaging before treatment
✗Underestimating extent of contamination
✗Not discussing amputation as possible option
LIKELY FOLLOW-UPS
"What is your threshold for recommending amputation?"
"How would you manage if staging shows pulmonary nodules?"
"What surveillance would you recommend after re-excision?"
"Is there a role for adjuvant therapy in recurrent disease?"
VIVA SCENARIOChallenging

Differential Diagnosis - Child with Tibial Lesion

EXAMINER

"A 7-year-old child is referred with anterior tibial bowing and an incidental finding of a lytic lesion in the tibial diaphysis on X-ray. The lesion appears intracortical with slight expansion. The child is asymptomatic."

EXCEPTIONAL ANSWER
**Opening Statement:** "In a child under 10 with an asymptomatic anterior tibial cortical lesion and bowing, the main differential is between osteofibrous dysplasia (OFD) and osteofibrous dysplasia-like adamantinoma. Classic adamantinoma is rare in this age group." **Differential Diagnosis:** 1. Osteofibrous dysplasia (most likely) 2. OFD-like (differentiated) adamantinoma 3. Fibrous dysplasia 4. Non-ossifying fibroma (less likely given location) **Key Differentiating Features:** | Feature | OFD | OFD-like Adamantinoma | |---------|-----|----------------------| | Age | Under 10 | Adolescents | | Symptoms | Usually asymptomatic | May have pain | | Cytokeratin | Negative or minimal | Focal positive | | Behaviour | Self-limiting | Low malignant potential | **Investigation Approach:** "I would: 1. Complete radiographic series - AP and lateral 2. MRI to assess extent 3. Biopsy with immunohistochemistry for cytokeratin If cytokeratin is negative or only minimally positive, and histology shows pure OFD, this can be observed as most cases stabilise after skeletal maturity." **Management:** "For pure OFD: Observation with serial imaging. Consider bracing for significant bowing. Surgery reserved for pathological fracture or severe deformity. If epithelial component identified (OFD-like adamantinoma): Wide excision is recommended given malignant potential." **Follow-up:** "Close follow-up through skeletal maturity with annual imaging to detect any transformation."
KEY POINTS TO SCORE
Age helps differentiate OFD from adamantinoma
Cytokeratin immunostaining is key
OFD in children can be observed
OFD-like adamantinoma requires excision
COMMON TRAPS
✗Recommending immediate surgery for presumed OFD
✗Not performing immunohistochemistry on biopsy
✗Missing the relationship between OFD and adamantinoma
✗Not following OFD cases to skeletal maturity
LIKELY FOLLOW-UPS
"At what point would you intervene surgically for OFD?"
"Can OFD transform to adamantinoma?"
"How would you manage a pathological fracture in OFD?"
"What follow-up would you recommend after skeletal maturity?"

MCQ Practice Points

Location

Q: What is the most common location for adamantinoma?

A: Tibial diaphysis - 85% of adamantinomas occur in the mid-tibial shaft, characteristically involving the anterior cortex. This location is virtually pathognomonic. Other sites (fibula, humerus, femur) are rare.

Histology

Q: What is the characteristic histological feature of adamantinoma?

A: Biphasic pattern with epithelial nests or cords within an osteofibrous stroma. The epithelial cells are positive for cytokeratins 14 and 19 (but negative for CK8, CK18). This cytokeratin profile distinguishes it from metastatic carcinoma.

Treatment

Q: What is the surgical treatment of choice for adamantinoma?

A: Wide en bloc resection with adequate margins. Curettage is contraindicated and associated with up to 90% local recurrence. Even marginal excision has 30-50% recurrence. The minimum acceptable margin is wide (through normal tissue).

Prognosis

Q: What is the prognosis and metastasis rate for adamantinoma?

A: 10-year survival is approximately 92% with adequate surgical margins. Metastases occur in 15-30% of cases, primarily to lungs and lymph nodes. Late recurrence (up to 36 years post-surgery) mandates lifelong follow-up.

Imaging

Q: What is the characteristic radiographic appearance of adamantinoma?

A: "Soap-bubble" appearance - multilocular lytic lesion with sclerotic margins, eccentric in the anterior tibial cortex. The lesion may show cortical expansion without periosteal reaction. Skip lesions (multifocality) can occur in the same bone.

Australian Context

Epidemiology

Adamantinoma is rare in Australia, consistent with international incidence rates. The rarity of this tumour means that most cases should be managed at specialist sarcoma centres with experience in limb salvage surgery.

Referral Pathways

Suspected bone tumours should be referred to a specialist musculoskeletal oncology unit before biopsy. In Australia, major sarcoma units are located in capital cities with multidisciplinary teams including orthopaedic oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists.

Patients in rural and regional areas may require transfer to metropolitan centres for definitive management. Telemedicine can facilitate initial consultation and follow-up.

Treatment Considerations

Australian practice follows international guidelines with wide surgical resection as the standard of care. Access to reconstruction materials including allografts and custom prostheses is available through major tertiary centres.

Follow-up protocols are similar to international standards with lifelong surveillance recommended. The Australian healthcare system supports long-term follow-up through public and private oncology services.

ADAMANTINOMA

High-Yield Exam Summary

Key Diagnosis

  • •Tibial diaphysis location (85%) - anterior cortex
  • •Soap-bubble appearance on X-ray
  • •Biphasic histology - epithelial + osteofibrous
  • •Cytokeratin 14, 19 positive

Treatment Principles

  • •Wide en bloc resection mandatory
  • •NEVER curettage (90% recurrence)
  • •Excise biopsy tract with specimen
  • •Reconstruction: allograft, vascularised fibula, prosthesis

Prognosis

  • •10-year survival approximately 92%
  • •Metastases in 15-30% (lung, lymph nodes)
  • •Late recurrence up to 36 years
  • •Lifelong follow-up required

Exam Triggers

  • •Young adult with tibial diaphyseal lytic lesion
  • •Anterior cortex soap-bubble lesion
  • •Multilocular lytic with sclerotic margins
  • •Positive cytokeratin staining on biopsy

Common Mistakes

  • •Performing curettage or marginal excision
  • •Not staging with CT chest before surgery
  • •Forgetting to excise biopsy tract
  • •Stopping follow-up after 5 or 10 years
Quick Stats
Reading Time92 min
Related Topics

Aneurysmal Bone Cyst

Angiosarcoma

Biopsy Principles and Techniques in Orthopaedic Oncology

Chondroblastoma